Response to: 500 mg as bolus followed by an extended infusion of 1500 mg of meropenem every 8 h failed to achieve in one-third of the patients an optimal PK/PD against nonresistant... by Amol Kothekar, Jigeeshu Vasishtha Divatia, Sheila Nainan Myatra, Vikram Gota

Get full text

Therapeutic drug monitoring for imatinib: Current status and Indian experience by Brijesh Arora, Vikram Gota, Hari Menon, Manju Sengar, Reena Nair, Pankaj Patial, S D Banavali

Get full text

Comparison of PSA Response to Generic Versus Innovator (Zytiga) Formulations of Abiraterone in Metastatic CRPC: A Retrospective Analysis by Sharath Kumar, Amit Joshi, Apurva Takke, Diana Varghese, Shruti Pathak, Vanita Noronha, Kumar Prabhash, Vikram Gota

Get full text

Increasing early phase clinical trials capacity in India by Jerin Jose Cherian, Aruvi Poomali, Aparna Mukherjee, Taruna Madan Gupta, Bikash Medhi, Shoibal Mukherjee, Alangudi Sankaranarayanan, Nilanjan Saha, Vikram Gota, Ramachandra Subbaraya Gudde, Monika Pahuja, Saibal Das, Nabendu Sekhar Chatterjee, Rubina Bose, Nilima Kshirsagar, Rajeev Singh Raghuvanshi

Get full text

Study Protocol of a Prospective Phase 2 Study of Chlorophyllin for the Management of Brain Radionecrosis in Patients With Diffuse Glioma (CHROME) by Archya Dasgupta, Saranga Sawant, Abhishek Chatterjee, Vikram Gota, Arpita Sahu, Amitkumar Choudhari, Kajari Bhattacharya, Ameya Puranik, Indraja Dev, Aliasgar Moiyadi, Prakash Shetty, Vikas Singh, Nandini Menon, Sridhar Epari, Ayushi Sahay, Aekta Shah, Nazia Bano, Farnaz Shaikh, Aabha Jirage, Tejpal Gupta

Get full text